Physician

Naeemuddin Jatoi, M.D.

According to 2025 Medicare claims, Naeemuddin Jatoi, M.D. (NPI: 1922070333) practices internal medicine in the Decatur, IL market, with the plurality of this provider's patient population coming from Macon, IL. This provider's primary affiliated billing organization is HSHS MEDICAL GROUP INC (NPI: 1962644807; TIN: 263956318) and primary practice location at 62526-1964. Jatoi is affiliated with the IRCCO (ACO ID: A2619) and HSHS ACO, L.L.C. (ACO ID: A2783), participating under the MSSP model.

Jatoi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 563 traditional Medicare patients, billed 6,111 HCPCS/CPT codes, and received $213,179 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 11,821 prescription claims across 775 beneficiaries totaling $713,700 in drug costs, led by Eliquis (Apixaban). DME data shows 1,175 claims. Open Payments data shows 110 records totaling $1,863. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	653	9,642	$244,559
2016	741	13,297	$274,695
2017	756	9,026	$241,742
2018	820	7,143	$246,721
2019	794	11,628	$229,160
2020	665	8,106	$201,537
2021	648	7,806	$231,893
2022	578	6,458	$234,814
2023	548	5,850	$210,990
2024	563	6,111	$213,179

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	522	12,012	$631,233
2016	613	12,389	$597,311
2017	627	12,962	$586,313
2018	698	13,424	$613,920
2019	760	12,981	$605,264
2020	689	11,437	$617,270
2021	695	10,230	$621,351
2022	698	10,509	$665,861
2023	739	10,902	$758,038
2024	775	11,821	$713,700

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	310	1,306	$69,584
2016	443	1,497	$65,656
2017	342	1,359	$52,564
2018	406	1,596	$67,532
2019	484	1,579	$53,542
2020	360	1,339	$50,374
2021	296	1,079	$49,651
2022	328	1,089	$56,014
2023	367	1,200	$67,796
2024	349	1,175	$43,970

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	503	1,109	$84
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	217	253	$12
83036	Hemoglobin a1c level	209	312	$10
36415	Insertion of needle into vein for collection of blood sample	310	469	$9
81003	Automated urinalysis test	179	261	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	170	6,980	$134,710
Jardiance	Empagliflozin	51	3,328	$62,846
Xarelto	Rivaroxaban	33	2,130	$40,505
Ozempic	Semaglutide	41	1,316	$40,159
Farxiga	Dapagliflozin Propanediol	37	2,190	$39,962

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7031	Face mask interface, replacement for full face mask, each	N	25	59	$5,634
A7030	Full face mask used with positive airway pressure device, each	N	25	57	$5,045
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	14	$4,102
E0601	Continuous positive airway pressure (cpap) device	Y	20	127	$3,831
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	53	$3,813

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	110	$1,863	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Naeemuddin Jatoi, M.D.?

Tedicare shows public-source Medicare data for Naeemuddin Jatoi, M.D. (NPI 1922070333), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Naeemuddin Jatoi, M.D. have ACO affiliation data?

Naeemuddin Jatoi, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and HSHS ACO, L.L.C. (MSSP, ACO ID A2783).

What billing organization is linked to Naeemuddin Jatoi, M.D.?

Naeemuddin Jatoi, M.D. is linked to HSHS MEDICAL GROUP INC (billing NPI 1962644807) in the available physician profile data.

Does Naeemuddin Jatoi, M.D. have Open Payments data?

Naeemuddin Jatoi, M.D. has 110 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.